We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KB:NYSEKB Financial Group Inc Analysis

Data as of 2026-05-26 - not real-time

$106.28

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

KB Financial Group is trading at $106.28, just below its 20‑day SMA of 106.83 but comfortably above the 50‑day (105.29) and 200‑day (92.87) averages, indicating a short‑term pull‑back within a longer‑term bullish framework. The RSI sits at 50.6, suggesting neutral momentum, while the MACD histogram remains negative, flagging bearish pressure despite an overall bullish trend direction. Valuation metrics are compelling: a trailing P/E of 9.96 versus an industry average of 16.81 and a forward P/E of 8.57 point to the stock being undervalued on earnings grounds, even as the price‑to‑book ratio of 4.09 is relatively high. The dividend yield of 2.9% with a modest 27% payout ratio underscores cash‑flow sustainability, though operating cash flow is currently negative. Volatility is elevated at roughly 31% over the past 30 days and a computed beta of 1.39 signals higher market sensitivity, while the max drawdown of 17.5% reflects recent downside risk. The upside potential of about 22% above the current price, combined with increasing volume, supports a positive medium‑term outlook, even as the annual report filing hints at ongoing strategic positioning across multiple geographies.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near immediate support at $101.09
  • Increasing volume indicating interest
  • Bearish MACD histogram despite overall bullish trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued earnings multiples relative to peers
  • Attractive dividend yield with low payout ratio
  • Projected upside of ~22% and steady revenue growth of 15%

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustainable dividend and moderate ROE (~10%)
  • Exposure to South Korean market and diversified international operations
  • Elevated volatility and beta suggesting higher systematic risk

Key Metrics & Analysis

Financial Health

Revenue Growth15.20%
Profit Margin36.58%
P/E Ratio10.0
ROE9.99%
ROA0.76%
P/B Ratio4.1
Op. Cash Flow$-26548566491136
Industry P/E16.8

Technical Analysis

TrendBullish
RSI50.6
Support$101.09
Resistance$111.88
MA 20$106.83
MA 50$105.29
MA 200$92.87
MACDBearish
VolumeIncreasing
Fear & Greed Index91.39

Valuation

Target Price$129.63
Upside/Downside21.97%
GradeUndervalued
TypeBlend
Dividend Yield2.90%

Risk Assessment

Beta1.39
Volatility30.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.